Tom Saldeen

8.5k total citations
248 papers, 7.0k citations indexed

About

Tom Saldeen is a scholar working on Pulmonary and Respiratory Medicine, Nutrition and Dietetics and Surgery. According to data from OpenAlex, Tom Saldeen has authored 248 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Pulmonary and Respiratory Medicine, 43 papers in Nutrition and Dietetics and 39 papers in Surgery. Recurrent topics in Tom Saldeen's work include Blood properties and coagulation (33 papers), Fatty Acid Research and Health (32 papers) and Protease and Inhibitor Mechanisms (27 papers). Tom Saldeen is often cited by papers focused on Blood properties and coagulation (33 papers), Fatty Acid Research and Health (32 papers) and Protease and Inhibitor Mechanisms (27 papers). Tom Saldeen collaborates with scholars based in Sweden, United States and Italy. Tom Saldeen's co-authors include Jawahar L. Mehta, Dayuan Li, Rolf Wallin, Wilmer W. Nichols, J. L. Mehta, Daniel Lawson, Riitta Luostarinen, J. Modig, Kenneth H. Rand and Paulette Mehta and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Tom Saldeen

245 papers receiving 6.5k citations

Peers

Countries citing papers authored by Tom Saldeen

Since Specialization

Citations

This map shows the geographic impact of Tom Saldeen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Saldeen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Saldeen more than expected).

Fields of papers citing papers by Tom Saldeen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Saldeen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Saldeen. The network helps show where Tom Saldeen may publish in the future.

Co-authorship network of co-authors of Tom Saldeen

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Saldeen. A scholar is included among the top collaborators of Tom Saldeen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Saldeen. Tom Saldeen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Attenuation of Tissue P-Selectin and MCP-1 Expression and Intimal Proliferation by AT1 Receptor Blockade in Hyperlipidemic Rabbits 2001 ·Biochemical and Biophysical Research Communications ·(unknown), (unknown), Tom Saldeen, M. Ian Phillips, J. L. Mehta	15
2	Seropositivity against chlamydia pneumoniae in patients with coronary atherosclerosis 2000 ·Clinical Cardiology ·Francesco Romeo, (unknown), (unknown), (unknown), Katharina Ericson, Tom Saldeen, Jawahar L. Mehta	15
3	γ-Tocopherol Decreases Ox-LDL-Mediated Activation of Nuclear Factor-κB and Apoptosis in Human Coronary Artery Endothelial Cells 1999 ·Biochemical and Biophysical Research Communications ·Dayuan Li, Tom Saldeen, Jawahar L. Mehta	53
4	Age-dependent Modulation of Heparan Sulfate Structure and Function 1998 ·Journal of Biological Chemistry ·Emadoldin Feyzi, Tom Saldeen, Erik Larsson, Ulf Lindahl, Markku Salmivirta	130
5	Inogatran, a novel direct low molecular weight thrombin inhibitor, given with, but not after, tissue-plasminogen activator, improves thrombolysis. 1996 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), Wilmer W. Nichols, Christer Mattsson, A.‐C. Teger‐Nilsson, Tom Saldeen, J Mehta	17
6	Effekter av kombination av låg dos acetylsalicylsyra och stabil fiskolja på eikosanoider. 1996 ·(unknown), (unknown), (unknown), Tom Saldeen	1
7	Whole blood production of thromboxane, prostacyclin and leukotriene B4 after dietary fish oil supplementation in man: effect of vitamin E 1996 ·Prostaglandins Leukotrienes and Essential Fatty Acids ·Karin Engström, Riitta Luostarinen, Tom Saldeen	10
8	Failure of prostacyclin analog iloprost to sustain coronary blood flow after recombinant tissue-type plasminogen-induced thrombolysis in dogs 1993 ·American Heart Journal ·Wilmer W. Nichols, Fabio Nicolini, Saeed R. Khan, Tom Saldeen, J. L. Mehta	7
9	Reliable typing of DNA amplified from formalin-fixed tissue biopsies. 1992 ·Genome Research ·Charlotta Ingvoldstad Malmgren, Inger Gustavsson, (unknown), Tom Saldeen, Ulf Gyllensten	7
10	Fibrin (ogen)-derived peptide Bβ 30–43 is a sensitive marker of activated neutrophils during fibrinolytic-treated acute myocardial infarction in man 1992 ·American Heart Journal ·Christer Sylvén, Jihong Chen, Kurt Bergström, Lena Björkman, Rolf Wallin, Tom Saldeen	6
11	The Effects of Fish Oil on Triglycerides, Cholesterol, Fibrinogen and Malondialdehyde in Humans Supplemented with Vitamin E 1991 ·Journal of Nutrition ·Olle Haglund, Riitta Luostarinen, Rolf Wallin, L Wibell, Tom Saldeen	142
12	Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction 1990 ·Journal of the American College of Cardiology ·Jay Dinerman, Jawahar L. Mehta, Tom Saldeen, Scott S. Emerson, Rolf Wallin, Rajesh K. Davda, Andrew Davidson	154
13	Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: Correlation with age and serum triglyceride concentrations 1987 ·Journal of the American College of Cardiology ·Jawahar L. Mehta, Paulette Mehta, Daniel Lawson, Tom Saldeen	204
14	Cutaneous reactions to two fibrin-derived peptides 1981 ·Acta Dermato Venereologica ·Bengt Gerdin, L Juhlin, Tom Saldeen	3
15	Pulmonary Insufficiency in the Rat after Intravascular Coagulation and Inhibition of Fibrinolysis 1981 ·European Surgical Research ·Bengt Gerdin, (unknown), Tom Saldeen	13
16	Immunosuppressive effect of vasoactive peptides derived from human fibrinogen 1980 ·Thrombosis Research ·Bengt Gerdin, Tom Saldeen, W. Roszkowski, S Szmigielskí, (unknown), M Kopeć	13
17	Differential degradation by plasmin of fragment E derived from fibrin and fibrinogen 1980 ·Thrombosis Research ·Rolf Wallin, Makonnen Belew, Bengt Gerdin, Tom Saldeen	4
18	Effect of hepatectomy on the posttraumatic fibrinolysis inhibition and the primary fibrinolysis inhibitor in the rat 1980 ·Thrombosis Research ·(unknown), H. Jacobsson, Tom Saldeen	12
19	The Microembolism Syndrome 1977 ·Thrombosis and Haemostasis ·Tom Saldeen	39
20	Fibrin Degradation Products and Vascular Permeability 1977 ·Thrombosis and Haemostasis ·Bengt Gerdin, (unknown), Olle Lindquist, Tom Saldeen, Erik Svensjö	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact